Form 4: Cyanotech Director Michael Davis Increases Stake in Company

Sentiment:

SEC Form 4 Filing


Director Michael Davis increased his holdings in Cyanotech through open market purchases executed under a pre-arranged 10b5-1 trading plan.

Summary

  • On September 25 and 26, 2024, Michael Davis, a director and 10% owner of Cyanotech Corporation, purchased 5,000 shares each day at a price of $0.77 per share.
  • These purchases were made under a pre-existing 10b5-1 trading plan adopted on March 6, 2024.
  • Following these transactions, Davis's indirect beneficial ownership totals 1,450,440 shares held in the Michael Arlen Davis Revocable Trust.
  • Davis also has indirect ownership through his spouse (31,250 shares), as co-trustee for the Nyracai Davis Irr. Trust and the Nettizanne J. Davis Irr. Trust (150,000 shares), and as trustee for the Nettizanne Johnstone Davis GST Exempt Trust (58,000 shares) and the Nyracai Johnstone Davis GST Exempt Trust (58,789 shares).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director's purchase indicates confidence, but it's part of a pre-planned trading strategy.

Positives

  • The director's purchase of shares could be interpreted as a positive signal about their confidence in the company's future prospects.
  • The purchases were made under a pre-arranged 10b5-1 trading plan, which suggests the transactions were planned and not based on any recent non-public information.

Industry Context

Insider buying is often monitored by investors as an indicator of management's confidence in the company's prospects. Purchases by a director, especially a 10% owner, can be seen as a positive sign.

Stakeholder Impact

  • The director's increased stake could boost investor confidence.
  • The transactions have a minimal impact on employees, customers, suppliers, and creditors.

Key Dates

DateDescription
03-06-2024Adoption date of the 10b5-1(c) plan
09/25/2024Date of first reported transaction: purchase of 5,000 shares at $0.77
09/26/2024Date of second reported transaction: purchase of 5,000 shares at $0.77
09/27/2024Date of Form 4 filing

Keywords

Cyanotech, Michael Davis, insider trading, Form 4, beneficial ownership, 10b5-1 plan, stock purchase, director, shareholder

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.